Head-to-head · computed 2026-08-11
Direct Meds vs TMates
Direct Meds: Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery. TMates: TMates is a compounded GLP-1 telehealth service that includes medication and visits in one bundled monthly price. It offers both semaglutide and tirzepatide, with a 12-month plan that brings tirzepatide to $167/mo — the lowest committed-plan figure for tirz outside of bmiMD and NexLife.
Tirzepatide
| Direct Meds | TMates | |
|---|---|---|
| All-in maintenance | $399/mo | $297/mo |
| Best plan rate | $399/mo | $167/mo |
| 12-month total | $4,788 | $2,004 |
| Status | Reported · 2026-07-25 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $297 a month undercuts Direct Meds's $399 by $102 a month at the 10 mg/wk maintenance basis — $1,224 across a year. TMates's figure is reported (captured 2026-07-14) and Direct Meds's is reported (captured 2026-07-25); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's tirzepatide ladder runs $399 a month billed monthly. TMates's runs $297 a month billed monthly, and $167 a month on a twelve-month plan. On the twelve-month basis TMates's $2,004 beats Direct Meds's $4,788 by $2,784 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Semaglutide
| Direct Meds | TMates | |
|---|---|---|
| All-in maintenance | $297/mo | $249/mo |
| Best plan rate | $297/mo | $158/mo |
| 12-month total | $3,564 | $1,896 |
| Status | Reported · 2026-07-25 | Reported · 2026-07-14 |
The arithmetic
On the figures our desk holds, TMates's $249 a month undercuts Direct Meds's $297 by $48 a month at the 2.4 mg/wk maintenance basis — $576 across a year. TMates's figure is reported (captured 2026-07-14) and Direct Meds's is reported (captured 2026-07-25); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Direct Meds's semaglutide ladder runs $297 a month billed monthly. TMates's runs $249 a month billed monthly, and $158 a month on a twelve-month plan. On the twelve-month basis TMates's $1,896 beats Direct Meds's $3,564 by $1,668 — with the winner's figure resting on a committed twelve-month plan, a structural difference that matters if you might stop early.
Structure, side by side
Direct Meds
- MembershipNone
- Dose policyAll-inclusive per format; injection and sublingual priced separately
- CommitmentMonthly (no commitment indicated)
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
TMates
- MembershipNone
- Dose policyStructured titration; medication and provider visits included in price
- Commitment12-month plan or month-to-month; substantial difference in rates
- CancellationPer provider terms
- PharmacyPartner 503A pharmacy (not publicly named)
What our desk is watching on each
Direct Meds: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
TMates: The $158/mo (sema) and $167/mo (tirz) headline figures are 12-month plan rates; month-to-month is $249 (sema) and $297 (tirz) — some of the widest start-to-commitment spreads in the index. Reported status from RangeYourself 2026-07-14 verification.
Questions people ask
Is Direct Meds or TMates cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Direct Meds vs TMates miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Direct Meds and TMates cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at Direct Meds and $2,004 at TMates — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Direct Meds · TMates. Official sites: Direct Meds ↗ · TMates ↗. Nothing here is medical advice.